1. Home
  2. TPCS vs RVPH Comparison

TPCS vs RVPH Comparison

Compare TPCS & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TPCS
  • RVPH
  • Stock Information
  • Founded
  • TPCS 1956
  • RVPH 2006
  • Country
  • TPCS United States
  • RVPH United States
  • Employees
  • TPCS N/A
  • RVPH N/A
  • Industry
  • TPCS Metal Fabrications
  • RVPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • TPCS Industrials
  • RVPH Health Care
  • Exchange
  • TPCS Nasdaq
  • RVPH Nasdaq
  • Market Cap
  • TPCS 42.6M
  • RVPH 32.8M
  • IPO Year
  • TPCS N/A
  • RVPH N/A
  • Fundamental
  • Price
  • TPCS $3.71
  • RVPH $0.34
  • Analyst Decision
  • TPCS
  • RVPH Strong Buy
  • Analyst Count
  • TPCS 0
  • RVPH 5
  • Target Price
  • TPCS N/A
  • RVPH $9.00
  • AVG Volume (30 Days)
  • TPCS 30.4K
  • RVPH 2.4M
  • Earning Date
  • TPCS 04-08-2025
  • RVPH 08-13-2025
  • Dividend Yield
  • TPCS N/A
  • RVPH N/A
  • EPS Growth
  • TPCS N/A
  • RVPH N/A
  • EPS
  • TPCS N/A
  • RVPH N/A
  • Revenue
  • TPCS $33,154,058.00
  • RVPH N/A
  • Revenue This Year
  • TPCS N/A
  • RVPH N/A
  • Revenue Next Year
  • TPCS N/A
  • RVPH N/A
  • P/E Ratio
  • TPCS N/A
  • RVPH N/A
  • Revenue Growth
  • TPCS 8.71
  • RVPH N/A
  • 52 Week Low
  • TPCS $2.05
  • RVPH $0.30
  • 52 Week High
  • TPCS $4.42
  • RVPH $4.28
  • Technical
  • Relative Strength Index (RSI)
  • TPCS 52.13
  • RVPH 27.45
  • Support Level
  • TPCS $3.52
  • RVPH $0.72
  • Resistance Level
  • TPCS $3.88
  • RVPH $0.83
  • Average True Range (ATR)
  • TPCS 0.23
  • RVPH 0.07
  • MACD
  • TPCS -0.01
  • RVPH -0.03
  • Stochastic Oscillator
  • TPCS 51.25
  • RVPH 9.67

About TPCS TechPrecision Corporation Common stock

Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components.

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.

Share on Social Networks: